1st Order Pharmaceuticals is a US-based pharmaceutical company specializing in early-stage drug development, located in Research Triangle Park, North Carolina.

We focus on advancing 1OP-2198, an IND-ready small molecule potassium channel opener, targeting neurological and neuro-ophthalmological conditions.

Our approach combines established PK/PD modeling with innovative formulation strategies and a robust intellectual property portfolio to create a compelling value proposition for ring-fencing therapeutic indications.

Founded in 2013, 1st Order Pharmaceuticals leverages scientific expertise and a strategic development path to address unmet medical needs in epilepsy and related disorders. We are dedicated to advancing novel therapies through rigorous research and development.

1OP-2198 | 1st Order Pharmaceuticals, Inc.

Product description

11st Order Pharmaceuticals, Inc. Research Triangle Park, United States (US)

Price: N/A

1
1st Order Pharmaceuticals, Inc.
Research Triangle Park, United States (US)